000 | 01664 a2200421 4500 | ||
---|---|---|---|
005 | 20250517170733.0 | ||
264 | 0 | _c20181003 | |
008 | 201810s 0 0 eng d | ||
022 | _a1931-8448 | ||
024 | 7 |
_a10.1089/mdr.2017.0048 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNachappa, Somanna Ajjamada | |
245 | 0 | 0 |
_aDetection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India. _h[electronic resource] |
260 |
_bMicrobial drug resistance (Larchmont, N.Y.) _cMay 2018 |
||
300 |
_a377-385 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 |
_aCatalytic Domain _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndia |
650 | 0 | 4 |
_aIsoniazid _xpharmacology |
650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
650 | 0 | 4 |
_aMolecular Docking Simulation _xmethods |
650 | 0 | 4 |
_aMultiplex Polymerase Chain Reaction _xmethods |
650 | 0 | 4 |
_aMutation _xdrug effects |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 |
_aSequence Analysis, DNA _xmethods |
650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
700 | 1 | _aNeelambike, Sumana M | |
700 | 1 | _aAmruthavalli, Chokkanna | |
700 | 1 | _aRamachandra, Nallur B | |
773 | 0 |
_tMicrobial drug resistance (Larchmont, N.Y.) _gvol. 24 _gno. 4 _gp. 377-385 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/mdr.2017.0048 _zAvailable from publisher's website |
999 |
_c27470950 _d27470950 |